Sarah Joanne Williams's most recent trade in AN2 Therapeutics Inc was a trade of 327 Common Stock done at an average price of $1.1 . Disclosure was reported to the exchange on March 3, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| AN2 Therapeutics Inc | Sarah Joanne Williams | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 1.06 per share. | 03 Mar 2026 | 327 | 66,848 | - | 1.1 | 347 | Common Stock |
| AN2 Therapeutics Inc | Sarah Joanne Williams | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2026 | 48,375 | 67,175 | - | 0 | Common Stock |